Edesa Biotech, Inc. (EDSA)
NASDAQ: EDSA · Real-Time Price · USD
4.000
+0.030 (0.76%)
Sep 24, 2026, 9:43 AM EDT - Market open
Edesa Biotech Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
17
Market Cap
54.05M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | - | - | - |
| Sep 30, 2024 | - | - | - |
| Sep 30, 2023 | - | - | - |
| Sep 30, 2022 | - | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Heron Therapeutics | 151.18M |
| Xilio Therapeutics | 64.09M |
| Apollomics | 8.84M |
| Hyperion DeFi | 1.40M |
| ImageneBio | 800.00K |
| Clene | 197.00K |
| Serina Therapeutics | 130.00K |
| Impact BioMedical | 35.00K |
EDSA News
- 5 weeks ago - Edesa Biotech 3.87M share Spot Secondary priced at $5.50 - TheFly
- 5 weeks ago - Edesa Biotech Announces Pricing of $25.0 Million Public Offering - GlobeNewsWire
- 5 weeks ago - Edesa Biotech announces offering of common stock and warrants, no amount given - TheFly
- 5 weeks ago - Edesa Biotech Announces Proposed Public Offering - GlobeNewsWire
- 5 weeks ago - Edesa Biotech Reports Fiscal 3rd Quarter 2026 Results - GlobeNewsWire
- 2 months ago - Edesa Biotech files to sell 729,241 common shares for holders - TheFly
- 2 months ago - Edesa Biotech reinstated with a Buy at Brookline - TheFly
- 3 months ago - Edesa Biotech announces $3.5M private placement - TheFly